BeiGene (BGNE) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BGNE is expected to report earnings to rise 46.96% to -169 cents per share on November 07

Q3'24

Est.

$-1.69

Q2'24

Beat

by $1.04

Q1'24

Beat

by $0.51

Q4'23

Beat

by $0.01

Q3'23

Beat

by $5.39

The last earnings report on August 07 showed earnings per share of -114 cents, beating the estimate of -219 cents. With 394.25K shares outstanding, the current market capitalization sits at 24.38B.

View a ticker or compare two or three

Compare

BGNE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BGNE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BGNE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

c/o Mourant Governance Services (Cayman) Limited

Phone

+1 345 949-4123

Employees

10600

Web

https://www.beigene.com